Concept Life Sciences Intensifies Its Push Into Medicinal Chemistry With New Senior Appointment At Peakdale Molecular Ltd.
Peakdale Molecular, part of the Concept Life Sciences Group, has appointed Dr Paul Bradley as new Head of Chemistry at the company’s Discovery Park site in Sandwich, Kent.
Peakdale Molecular is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences industries. Dr Bradley joins the team with extensive experience across multiple therapeutic areas in drug discovery having previously worked for companies such as Charnwood Molecular Ltd, Pfizer and Knoll Pharmaceuticals.
Speaking about his new role Dr Bradley said “It is a fantastic time to be joining Peakdale as the company is experiencing an unprecedented demand for its chemistry services. The appointment of both Heads of Chemistry and Biology is very exciting and will enable the company to expand its offering to prosecute fully integrated medicinal chemistry projects for its clients.”
Dr Paul Doyle, COO of Peakdale commented: “We are thrilled that Paul has joined our team.
Our aim is to accelerate our customers’ discovery initiatives through innovation, and Paul’s broad range of skills, knowledge and experience will prove to be invaluable in helping us achieve this and support both new and existing clients. His appointment is not only important to the future growth of Peakdale Molecular, but it also further bolsters our credentials and experience in the scientific arena.”
ENDS
Notes to editors:
• Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences.
• Peakdale is renowned for skills in problem-solving and open communications, and its scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives. Peakdale Molecular operates on two sites, from its headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
• For more information about Peakdale Molecular visit http://www.peakdale.co.uk/
Peakdale Molecular is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences industries. Dr Bradley joins the team with extensive experience across multiple therapeutic areas in drug discovery having previously worked for companies such as Charnwood Molecular Ltd, Pfizer and Knoll Pharmaceuticals.
Speaking about his new role Dr Bradley said “It is a fantastic time to be joining Peakdale as the company is experiencing an unprecedented demand for its chemistry services. The appointment of both Heads of Chemistry and Biology is very exciting and will enable the company to expand its offering to prosecute fully integrated medicinal chemistry projects for its clients.”
Dr Paul Doyle, COO of Peakdale commented: “We are thrilled that Paul has joined our team.
Our aim is to accelerate our customers’ discovery initiatives through innovation, and Paul’s broad range of skills, knowledge and experience will prove to be invaluable in helping us achieve this and support both new and existing clients. His appointment is not only important to the future growth of Peakdale Molecular, but it also further bolsters our credentials and experience in the scientific arena.”
ENDS
Notes to editors:
• Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences.
• Peakdale is renowned for skills in problem-solving and open communications, and its scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives. Peakdale Molecular operates on two sites, from its headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
• For more information about Peakdale Molecular visit http://www.peakdale.co.uk/